Clinical Trial Update: Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating immunogenicity and safety of a diphtheria, tetanus, and pertussis vaccine in 3-month-old infants; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• dTap Vaccine (Diphtheria and tetanus toxoids and acellular pertussis vaccine)

Snippet

Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Conditions: Healthy Volunteers | Phase 3 | Status: RECRUITING